Skip to content
Tuesday 25 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,854.32
+0.35%
DAX
26,106.60
-0.11%
CAC 40
8,453.01
0.00%
STOXX 50
6,447.98
-0.22%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Tuesday 27 August 2019 2:39 pm  |  Updated:  Tuesday 27 August 2019 10:06 pm

Big tobacco: Philip Morris and Altria start talks over $210bn mega-merger as Marlboro-makers seek to light up alternative products

By: August Graham

Add as a preferred source on Google

One of the world’s most hotly anticipated mega-mergers kicked off yesterday as tobacco giants Philip Morris International (PMI) and Altria said they were in talks to form a $210bn (£170bn) behemoth.

The deal would reunite two companies that split up in 2008 amid regulatory pressures at the time.

Read more: Juul raises $325m to fund global expansion of e-cigarette range

In recent years, both businesses have put alternative nicotine products such as e-cigarettes at the front and centre of their strategies. 

The merger would be the fourth largest on record, according to data from Refinitiv.

Analysts have suggested for some time that Altria might want to take PMI back into its fold a decade after they separated. 

Yesterday, Altria, which owns Marlboro, confirmed it was in discussions over an all-stock merger of equals. 

Declining traditional cigarette sales are putting pressure on the sector, but the global e-cigarette market hit $11bn last year and is expected to grow eight per cent per year over the next half-decade. 

“With disruption facing the world of tobacco, we can see some merit in a re-merger,” Bernstein analyst Callum Elliott said in a note.

An agreement between the two companies could help them market each other’s e-cigarettes, other analysts have said.

Altria already plans to market PMI’s Iqos – a heated tobacco product which won US approval in April – to American consumers. 

Read more

Astrazeneca share price tumbles on $400bn megamerger talks

Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure

Meanwhile, Altria bought a 35 per cent stake in popular vape pen maker Juul for $12.8bn late last year. 

Bonnie Herzog, managing director at Wells Fargo Securities, said ahead of the announcement that PMI would be an ideal partner to help the younger Juul expand beyond the US.

Elliott said: “The combined entity – Philip Morris 2.0 – could present a united front” on alternative products, and “go about a coordinated global brand-building exercise the same way Philip Morris originally built Marlboro.”

Shares in Altria initially jumped around 10 per cent, but they closed down  almost four per cent after CNBC reported that there would be no premium on the deal.

Philip Morris shares closed down 7.76 per cent last night.

The deal would solidify the US as the place to be for mega-mergers this year. According to data from Mergermarket, eight of the 10 biggest deals in 2019 have had US buyers. 

Read more: British American Tobacco boosted by vaping sales

US companies have spent 1.9 per cent more on mergers and acquisitions (M&A) this year compared to 2018, although the number of deals has fallen, showing a drive towards bigger acquisitions. 

Meanwhile, Europe has dropped off the M&A radar, with 16 per cent fewer deals and 19 per cent less spent.

Main image credit: Getty

Read more

Astrazeneca explores $400bn megadeal with US rival 

AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Retail

Trending Articles

  • Can debt-ridden Morrisons become a Big Four supermarket again?

  • Ratcliffe’s Ineos saves Runcorn plant

  • As it happened: Stocks rally; US to unveil ‘economic D-Day’ Iran sanctions

  • Amazon says it buys books in bulk to ‘improve products’

  • HMRC mansion tax inspectors to target homes for property valuations

More from Morning Wire

  • Astrazeneca share price tumbles on $400bn megamerger talks

    Investing
    Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure
  • Astrazeneca explores $400bn megadeal with US rival 

    Markets
    AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.
  • Britain needs a new Richard Branson

    Opinion
    Richard Branson in a suit, holding an umbrella and bowler hat, smiling in a swimming pool
  • KKR to Acquire a 50% Stake in a Portfolio of Developed Renewable Assets from TotalEnergies Across Europe

    Business Wire
  • Exclusive: Former Formula 1 figure invests £100k into new Pacer app dubbed ‘Sports Tinder’

    Sport
    White Martini Racing Formula 1 car on a grey track with green grass borders, in motion during a race.
  • Competition watchdog clears Paramount Warner Bros acquisition

    Media
    Paramount, Netflix, Warner logos; media giants intensifying streaming competition and strategic industry shifts
  • On this day: the birth of press freedom

    Opinion
    Black and white illustration of the Crown v. Zenger trial, featuring lawyers and observers in a courtroom.
  • Meta trial risks reputational damage that ‘dwarfs’ financial hit

    Tech
    Mark Zuckerberg in a dark suit, looking intently with a red light blurred in the background
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook